UBE2I Antikörper (N-Term)

Produktnummer ABIN184894

Produktdetails anti-UBE2I Antikörper

Target: UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))

Bindungsspezifität: N-Term

Reaktivität: Human, Ratte

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser UBE2I Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Verwendungszweck: UBE2I

Sequenz: SGIALSRLAQ ERK

Spezifität: Reported variants represent identical protein: NP_919237.1, NP_003336.1, NP_919236.1, NP_919235.1

Kreuzreaktivität: Hund, Human, Maus, Ratte

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence SGIALSRLAQERK-C, from the N Terminus of the protein sequence according to NP_003336.1, NP_919235.1, NP_919236.1, NP_919237.1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry: In paraffin embedded Human Kidney, shows nuclear staining of some epithelial cells of glomeruli and renal tubules. Recommended concentration: 1 μg/mL.

Western Blot: Approx 17 kDa band observed in Human Kidney lysates and in Rat Ovary, Heart and Testis lysates (calculated MW of 18.0 kDa according to Human NP_003336.1). Recommended concentration: 0.1-0.3 μg/mL. Primary incubation was 1 hour.

Peptide ELISA: antibody detection limit dilution 1:64000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu UBE2I

Target: UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))

Andere Bezeichnung: UBE2I (UBE2I Produkte)

Synonyme: C358B7.1 antikoerper, P18 antikoerper, UBC9 antikoerper, ubc9 antikoerper, ube2ia antikoerper, zUbc9 antikoerper, 5830467E05Rik antikoerper, F830028O17Rik antikoerper, Ubce2i antikoerper, Ubce9 antikoerper, UbcE2A antikoerper, ubce9 antikoerper, T13J8.70 antikoerper, T13J8_70 antikoerper, UBIQUITIN-PROTEIN LIGASE antikoerper, ubiquitin conjugating enzyme 9 antikoerper, ubiquitin conjugating enzyme E2 I antikoerper, ubiquitin-conjugating enzyme E2Ib antikoerper, ubiquitin-conjugating enzyme E2L antikoerper, ubiquitin-conjugating enzyme E2I antikoerper, ubiquitin conjugating enzyme E2I S homeolog antikoerper, ubiquitin conjugating enzyme 9 antikoerper, SUMO-conjugating enzyme UBC9 antikoerper, UBE2I antikoerper, ube2ib antikoerper, UBE2L antikoerper, Ube2i antikoerper, ube2i.S antikoerper, UBC9 antikoerper, ubc-9 antikoerper, LOC108703134 antikoerper

Hintergrund: UBE2I, ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast), C358B7.1, P18, UBC9, SUMO-1-protein ligase, ubiquitin carrier protein, ubiquitin conjugating enzyme 9, ubiquitin-conjugating enzyme E2I, ubiquitin-conjugating enzyme E2I (homologous to yeast U

Gen-ID: 7329, 22196, 25573

NCBI Accession: NP_003336

Pathways: Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Ubiquitin Proteasome Pathway